Evidence map›Paper›PMID 39975996›Full record

ArticleNeuroreport2025

CB1 receptor coupling to extracellular regulated kinase via multiple Gαi/o isoforms.

Boyd R Rorabaugh, Daniel J Morgan

Abstract read
In one paragraph

Article in Neuroreport, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Boyd R RorabaughDepartment of Pharmaceutical Sciences, Marshall University School of Pharmacy.
Daniel J MorganDepartment of Pharmaceutical Sciences, Marshall University School of Pharmacy.

Funding

Mechanisms of cannabinoid toleranceR01DA044999 · NIDA · PENNSYLVANIA STATE UNIV HERSHEY MED CTR · PI GUINDON, JOSEE, MORGAN, DANIEL J · 2018 to 2022
$2.4M
NIDA NIH HHS R01 DA044999
6 · The paper itself

Abstract

Cannabinoid type 1 receptors (CB 1 Rs) play important roles in regulating neurotransmitter release, synaptic plasticity, cell differentiation, and survival. CB 1 R is coupled via pertussis toxin (PTX)-sensitive Gαi/o proteins to the activation of extracellular regulated kinase (ERK) signaling. However, there are multiple Gαi/o isoforms, and it is unknown which of these isoforms is responsible for CB 1 R-induced phosphorylation of ERK. The purpose of this study was to determine which Gαi/o isoform(s) couple CB 1 R to ERK phosphorylation. HEK293 cells stably expressing the mouse CB 1 R (CB 1 R-HEK cells) were transfected with either pcDNA3.1 or pcDNA3.1 encoding PTX-insensitive mutants of Gαo, Gαi1, Gαi2, or Gαi3. PTX was used to inactivate endogenous Gαi/o isoforms before cells were treated with vehicle, delta-9-tetrahydrocannabinol (∆ 9 -THC), or CP55940 and ERK phosphorylation was measured by western blotting. CP55940 induced robust phosphorylation of ERK in cells transfected with vector alone. This effect was completely abolished by PTX treatment. CP55940-induced ERK phosphorylation was rescued by expression of PTX-insensitive forms of Gαo, Gαi1, Gαi2, or Gαi3, indicating that the CB1 receptor can couple to ERK phosphorylation through each of these Gαi/o isoforms. Consistent with its actions as a partial agonist, ∆ 9 -THC induced nominal (two to four-fold) increases in ERK phosphorylation that did not reach statistical significance except in cells transfected with PTX-insensitive Gαi3. These data demonstrate that CB 1 R can couple to ERK phosphorylation through Gαo, Gαi1, Gαi2, or Gαi3 when stimulated with CP55940 (full agonist). However, ∆ 9 -THC (partial agonist)-induced ERK activation might require high levels of Gαi3 expression.

Indexed as

Extracellular Signal-Regulated MAP KinasesGTP-Binding Protein alpha Subunits, Gi-GoReceptor, Cannabinoid, CB1AnimalsHEK293 CellsHumansMicePertussis ToxinPhosphorylationProtein IsoformsExtracellular Signal-Regulated MAP KinasesGTP-Binding Protein alpha Subunits, Gi-GoPertussis ToxinProtein IsoformsReceptor, Cannabinoid, CB1

Identifiers

PMID39975996
PMCPMC11952984

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.